Home » Archive for August, 2012
Archive for August, 2012
FDA Approved Stribild, New Combination Pill For HIV Treatment For Some Patients
Aug. 29 | The U. S. Food and Drug Administration (FDA) approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection. Stribild...
Obesity And Cognitive Decline
Aug. 24 | According to a new study, people who are obese and also have high blood pressure and other risk factors called metabolic abnormalities may experience a faster decline in their cognitive skills over time than others. The study has been published in the...
FDA Approved Roche’s Lucentis To Treat Diabetic Macular Edema
Aug. 24 | The U.S. Food and Drug Administration (FDA) today approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes. An injection administered once a month...
FDA Approved Talon Therapeutics Marqibo To Treat Rare Type Of Leukemia
Aug. 24 | Talon Therapeutics’ Marqibo (vinCRIStine sulfate LIPOSOME injection) received accelerated approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia...
A New Technique To Reduce Side Effects Of Chemotherapy
Aug. 21 | Scientists claim to have developed a new technique which dramatically reduces the harmful side effects of chemotherapy by blocking an oxygen-sensitive enzyme and streamlining the blood flow. Researchers from VIB/KU Leuven, Belgium have found that chemotherapy...
Certain Blood Type May Increase Heart Disease Risk
Aug. 21 | According to Harvard School of Public Health Study people with blood type A, B, or AB had a higher risk for coronary heart disease when compared to those with blood type O. The new research published in Arteriosclerosis, Thrombosis and Vascular Biology,...
FDA Approved Weight-Management Drug Qsymia
Aug. 10 | The U.S. Food and Drug Administration (FDA) approved the weight loss drug Qsymia, but there is strong warning for certain patients, including pregnant women, who should not use it. Qsymia contains phentermine and topiramate in an extended-release formula,...
FDA Approved Kyprolis For Multiple Myeloma
Aug. 10 | The U.S. Food and Drug Administration (FDA) granted accelerated approval of Kyprolis (carfilzomib) for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including...
The ‘Polypill’, All-In-One Could Save Lives, Says Report
Aug. 10 | According to the report, an all-in-one “polypill” with the potential to save tens of thousands of lives each year in the U K could be available in less than two years. Results from a ground-breaking trial showed that the four-medicine pill dramatically...
.
